Everest Medicines today announced that it has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., Ltd. (“Vcare”),…
Browsing: Everest Medicines
– by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis Everest…
– and with 2024 1H Performance Growing Strongly – Everest Medicines Showcasing its Industry LeadershipRecently, Everest Medicines has announced another positive development.…